-
Document de presse | 2021.02.18
Improving immunotherapies for blood cancers: real-time exploration in the tumor
Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use of the immune system to act and belong to a class of treatment called "immunotherapies." But how do these antibodies function within the tumor? And how can we hope to improve their efficacy? Using innovative in vivo imaging approaches, scientists from the Institut Pasteur and Inserm visualized in...
-
Report | 2021.03.18
Hearing loss: stepping up research
In recent years, progress in research on hearing mechanisms and the factors responsible for hearing disorders has raised hopes for future preventive and curative therapies. Currently the only solutions for hearing loss are external hearing aids and cochlear implants. The issue is becoming increasingly urgent given the number of people affected by hearing loss, the most common sensory disorder in...
-
Document de presse | 2021.02.26
Covid-19: Keeping schools as safe as possible
A year into the pandemic, and confronted with continued resurgence in transmission, over 800 million schoolchildren, more than half the world’s student population, still face substantial disruptions to their education. These range from full school closures in 31 countries to reduced or part time academic schedules in another 48 countries. Some countries, such as Norway and France, chose largely...
-
News | 2021.03.01
BIGPICTURE: artificial intelligence for a European database of pathology images
The Institut Pasteur's Biological Image Analysis Unit is taking part in a new project selected by the EU's Innovative Medicines Initiative. The project, BIGPICTURE, aims to speed up the development of artificial intelligence (AI) in medicine, especially in biomedical image analysis.A new consortium selected by the EU's Innovative Medicines Initiative (IMI) intends to develop the biggest database...
-
News | 2021.03.01
How does hearing work?
What we generally refer to as the ear is only the visible part. In reality the ear is made up of three parts: the outer, middle and inner ear. The outer ear, also known as the auricle or pinna, serves as an acoustic antenna and sensor. Sounds enter the external auditory canal.Sound waves then cause the eardrum to vibrate. The eardrum is stretched across the middle ear, which is situated in a...
-
News | 2021.03.03
Primary Immunodeficiencies: launch of the second phase of the ATun-DIP's project in the North-Western regions of Tunisia
After more than three years of activities in the underprivileged regions of the Centre and South of Tunisia, the second phase of the ATun-DIP's project (Improvement of the management of Tunisian children suffering from Primary Immunodeficiency Diseases) started on February the 4th, 2021. The project, coordinated by the Institut Pasteur de Tunis in collaboration with several partners including the...
-
News | 2021.03.03
Argobio Studio
The Institut Pasteur is a scientific partner of Argobio Studio, a French start-up studio aiming at creating at least five ambitious therapeutic biotech spinouts over the next five years. Argobio will incubate early-stage, highly innovative therapeutic projects up to company creation and Series A venture funding in selected therapeutic areas.Prof. Stewart Cole, CEO of the Institut Pasteur, said: "...
-
News | 2021.03.08
Piecing together past epidemics by studying the human genome
Tuberculosis is one of the most deadly infectious diseases in the world, and it is the most deadly disease in Europe's history. It is generally caused by the Mycobacterium tuberculosis bacterium. Scientists have studied the impact of tuberculosis outbreaks on the human genome over the past 10,000 years.Our genome is partly shaped by natural selection. Genes that increase our chances of survival...
-
News | 2021.03.01
DECIDER: artificial intelligence to improve diagnosis and treatment of ovarian cancer
The Institut Pasteur's Systems Biology Group is a partner in a new international project on applications of artificial intelligence (AI) for the diagnosis and treatment of ovarian cancer. The project, entitled DECIDER, has been granted five-year funding by the European Union.The aim of the DECIDER project, funded by the European Union's Horizon 2020 program, is to improve personalized treatment...
-
News | 2021.03.11
2019-2023 Strategic Plan: Two new projects to boost the Institut Pasteur Innovation Accelerator
Two projects have been accepted into the Institut Pasteur Innovation Accelerator, an initiative to improve the development potential of the Institut Pasteur's research: a highly automated technological system involving bioassays and a partnership based on a French startup studio. The Institut Pasteur will be setting up the project Pfbioassays [in French] (Thierry Rose and Sébastien...
